Clinical Orthopaedics Clin Orthop Relat Res (2017) 475:1252–1261 ® and Related Research DOI 10.1007/s11999-016-5187-3 A Publication of The Association of Bone and Joint Surgeons® CLINICAL RESEARCH Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease? Jonathan A. Forsberg MD, PhD, Rikard Wedin MD, PhD, Patrick J. Boland MD, John H. Healey MD Received: 23 May 2016 / Accepted: 21 November 2016 / Published online: 1 December 2016 The Association of Bone and Joint Surgeons1 2016 Abstract options, and very short estimates could help identify those Background Objective means of estimating survival can who will not survive 1 month and should not undergo sur- be used to guide surgical decision-making and to risk-stratify gery. Thereby, an important use of this tool would be to help patients for clinical trials. Although a free, online tool (www. avoid unsuccessful and expensive surgery during the last pathfx.org) can estimate 3- and 12-month survival, recent month of life. work, including a survey of the Musculoskeletal Tumor Questions/Purposes We seek to provide a reliable, Society, indicated that estimates at 1 and 6 months after objective means of estimating survival in patients with surgery also would be helpful. Longer estimates
Clinical Orthopaedics and Related Research – Wolters Kluwer Health
Published: Dec 1, 2016
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera